Expand LNTH Menu
LNTH MENU

LNTH Latest Press Releases

-- May 2, 2024 --

Lantheus Reports First Quarter 2024 Financial Results Globe Newswire 7:00 AM

-- April 18, 2024 --

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time Globe Newswire 8:00 AM

-- March 28, 2024 --

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results Globe Newswire 7:30 AM

-- March 5, 2024 --

Lantheus to Present at the Leerink Partners Global Biopharma Conference 2024 Globe Newswire 8:30 AM
Perspective Therapeutics Acquires CGMP-Compliant Manufacturing Facility Globe Newswire 8:00 AM

-- March 4, 2024 --

Lantheus Announces the FDA Approval of DEFINITY (Perflutren Lipid Microsphere) for Pediatric Patients Globe Newswire 8:30 AM

-- February 28, 2024 --

Lantheus Announces Promotion of Amanda Morgan to Chief Commercial Officer Globe Newswire 8:30 AM

-- February 26, 2024 --

Lantheus to Present at the TD Cowen 44th Annual Health Care Conference Globe Newswire 8:30 AM

-- February 22, 2024 --

Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results Globe Newswire 7:00 AM

-- February 13, 2024 --

Lantheus Announces Collaboration to Provide Novel Tau Imaging Agent for Large Consortium Clinical Trial Sponsored by the National Institute on Aging Globe Newswire 8:30 AM

-- February 8, 2024 --

Lantheus to Host Fourth Quarter and Full Year 2023 Earnings Conference Call and Webcast on February 22, 2024, at 8:00 a.m. Eastern Time Globe Newswire 8:00 AM

-- January 23, 2024 --

Lantheus Announces CEO Succession Plan Globe Newswire 7:45 AM

-- January 11, 2024 --

Lantheus Announces Acceptance of its First-to-File ANDA for Generic LUTATHERA (Lutetium Lu 177 Dotatate) Globe Newswire 8:00 AM

-- January 9, 2024 --

Perspective Therapeutics Enters into Strategic Agreements with Lantheus Including Equity Investment, Co-Development Options, and Expansion of Manufacturing Capability Globe Newswire 8:00 AM
Lantheus Expands Radiopharmaceutical Oncology Pipeline via Strategic Agreements with Perspective Therapeutics Globe Newswire 8:00 AM
Lantheus Reports Preliminary Fiscal Year 2023 Revenue Globe Newswire 7:55 AM

-- January 3, 2024 --

Lantheus to Present at the 42nd Annual J.P. Morgan Healthcare Conference Globe Newswire 8:30 AM

-- December 18, 2023 --

Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer Globe Newswire 7:30 AM
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer Globe Newswire 7:30 AM